APA

Olsson S., Kjaer S. K., Sigurdsson K., Iversen O., Hernandez-Avila M., Wheeler C. M., Perez G., Brown D. R., Koutsky L. A., Tay E. H., García P., Ault K. A., Garland S. M., Leodolter S., Tang G. W. K., Ferris D. G., Paavonen J., Lehtinen M., Steben M., Bosch F. X., Dillner J., Joura E. A., Majewski S., Muñoz N., Myers E. R., Villa L. L., Taddeo F. J., Roberts C., Tadesse A., Bryan J., Maansson R., Vuocolo S., Hesley T. M., Saah A., Barr E. & Haupt R. M. (20101215). Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection. : Human vaccines.

Chicago

Olsson Sven-Eric, Kjaer Susanne K, Sigurdsson Kristján, Iversen Ole-Erik, Hernandez-Avila Mauricio, Wheeler Cosette M, Perez Gonzalo, Brown Darron R, Koutsky Laura A, Tay Eng Hseon, García Patricia, Ault Kevin A, Garland Suzanne M, Leodolter Sepp, Tang Grace W K, Ferris Daron G, Paavonen Jorma, Lehtinen Matti, Steben Marc, Bosch F Xavier, Dillner Joakim, Joura Elmar A, Majewski Slawomir, Muñoz Nubia, Myers Evan R, Villa Luisa L, Taddeo Frank J, Roberts Christine, Tadesse Amha, Bryan Janine, Maansson Roger, Vuocolo Scott, Hesley Teresa M, Saah Alfred, Barr Eliav and Haupt Richard M. 20101215. Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection. : Human vaccines.

Harvard

Olsson S., Kjaer S. K., Sigurdsson K., Iversen O., Hernandez-Avila M., Wheeler C. M., Perez G., Brown D. R., Koutsky L. A., Tay E. H., García P., Ault K. A., Garland S. M., Leodolter S., Tang G. W. K., Ferris D. G., Paavonen J., Lehtinen M., Steben M., Bosch F. X., Dillner J., Joura E. A., Majewski S., Muñoz N., Myers E. R., Villa L. L., Taddeo F. J., Roberts C., Tadesse A., Bryan J., Maansson R., Vuocolo S., Hesley T. M., Saah A., Barr E. and Haupt R. M. (20101215). Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection. : Human vaccines.

MLA

Olsson Sven-Eric, Kjaer Susanne K, Sigurdsson Kristján, Iversen Ole-Erik, Hernandez-Avila Mauricio, Wheeler Cosette M, Perez Gonzalo, Brown Darron R, Koutsky Laura A, Tay Eng Hseon, García Patricia, Ault Kevin A, Garland Suzanne M, Leodolter Sepp, Tang Grace W K, Ferris Daron G, Paavonen Jorma, Lehtinen Matti, Steben Marc, Bosch F Xavier, Dillner Joakim, Joura Elmar A, Majewski Slawomir, Muñoz Nubia, Myers Evan R, Villa Luisa L, Taddeo Frank J, Roberts Christine, Tadesse Amha, Bryan Janine, Maansson Roger, Vuocolo Scott, Hesley Teresa M, Saah Alfred, Barr Eliav and Haupt Richard M. Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection. : Human vaccines. 20101215.